Can video therapy help kids with cerebral palsy move better?

NCT ID NCT06486987

Ongoing Symptom relief Sponsor: Warren Lo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether constraint-induced movement therapy (CIMT) can be effectively delivered via video in the homes of 10 children aged 4-10 with hemiplegic cerebral palsy. The therapy involves encouraging use of the weaker arm while restraining the stronger one. Researchers will measure arm function before and after treatment to estimate how well this remote approach works, aiming to inform a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Constraint-induced movement therapy delivered by televideo
What this could lead to: If it works, this could provide a convenient home-based therapy option to improve arm function in children with hemiplegic cerebral palsy.
What could go wrong: This is a very small pilot study with only 10 participants, so results may not apply to all children. The therapy is delivered remotely, which may affect how well it works compared to in-person sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMIPLEGIC CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic hemiplegic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMIPLEGIC CEREBRAL PALSY

Contacts and locations

Locations

The Ohio State University School of Health and Rehabilitation Sciences

Columbus, Ohio, 43210, United States
Virginia Tech-Fralin Biomedical Research Institute

Roanoke, Virginia, 24016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.